相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。被撤回的出版物: Actin-like protein 8 executes a promoting function in the malignant progression of endometrial cancer: identification of a promising biomarker (Retracted article. See vol. 86, pg. 423, 2022)
Li Li et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2020)
Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
Dhanasekhar Reddy et al.
FRONTIERS IN ONCOLOGY (2020)
Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells
Shanwu Ma et al.
THORACIC CANCER (2020)
Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
Shanshan Lei et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer
Qiang Han et al.
ONCOTARGETS AND THERAPY (2019)
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
M. V. Giuli et al.
JOURNAL OF ONCOLOGY (2019)
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
Francesca Corti et al.
CANCER TREATMENT REVIEWS (2019)
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma
Bo Li et al.
MOLECULAR MEDICINE REPORTS (2019)
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Ricardo L. B. Costa et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance
Maria Luisa Gasparri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells
Xin Yue et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy
Lior Z. Braunstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation
Var Ruchi Sharma et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Adjunctive ultrasonography in breast cancer screening
Martin J. Yaffe et al.
LANCET (2016)
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Subtyping of Triple-Negative Breast Cancer: Implications for Therapy
Vandana G. Abramson et al.
CANCER (2015)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen et al.
NATURE (2014)
Tumor Subtype-Specific Cancer-Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
Jun Yao et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
Dimitrios Balafoutas et al.
BMC CANCER (2013)
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S. Guiu et al.
ANNALS OF ONCOLOGY (2012)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
分享论文
